Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set by Sarfaraz K. Niazi

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Sarfaraz K. Niazi

1268 pages missing pub info (editions)

nonfiction health science informative medium-paced
Powered by AI (Beta)
Loading...

Description

What's the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for la...

Read more

Community Reviews

Loading...

Content Warnings

Loading...